Sign Up Today and Learn More About InSightec Stock
Invest in or calculate the value of your shares in InSightec or other pre-IPO companies through EquityZen's platform.
InSightec Stock
InSightec develops and manufactures MR-guided Focused Ultrasound technology devices for image-guided acoustic surgery.
About InSightec Stock
Founded
1999
Headquarters
Dallas, TX, US
Notable Investor
Koch Disruptive Technologies
Total Funding
442M
Industries
InSightec is the pioneer and global leader in MR guided focused ultrasound technology for image guided acoustic surgery. ExAblate® 2000 system was the first system to use the MR guided focused ultrasound technology. The ExAblate system received CE mark in 2002 and the Food and Drug Administration (FDA) approval in 2004 for the treatment of symptomatic uterine fibroids. ExAblate received the European CE Mark for pain palliation of bone metastases in June 2007 and for adenomyosis in June 2010. This device has won numerous innovation awards and has been used to treat thousands of patients around the world.
InSightec Press Mentions
Stay in the know about the latest news on InSightec
Insightec raises $150 million six months after cutting 20% of staff
calcalistech • Jul 03, 2024
INSIGHTEC ANNOUNCES $150M FINANCING TO FUND CONTINUED GROWTH USA - English
prnewswire • Jul 03, 2024
Insightec raises $150M to support incisionless neurosurgery tech
massdevice • Jul 03, 2024
Insightec raises $150M to expand the therapeutic power of focused ultrasound
refreshmiami • Jul 03, 2024
Insightec Secures $150 Million to Beam in a New Era of Surgery
jewishbusinessnews • Jun 25, 2024
Investors in InSightec
Discover investors in InSightec stock and explore their portfolio companies
InSightec Management
Leadership team at InSightec
CFO
Roni Karie
CEO & Chairman
Maurice Ferre, M.D.
Join now and verify your accreditation status to gain access to:
- InSightec current valuation
- InSightec stock price
- Available deals in InSightec and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in InSightec stock?
Accredited investors can buy pre-IPO stock in companies like InSightec through EquityZen funds. These investments are made available by existing InSightec shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell InSightec stock?
Shareholders can sell their InSightec stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
